Brief summary of the agreement
Anyone is free:
· to copy, distribute, and display the work;
· to make derivative works;
· to make commercial use of the work;
Under the following conditions: Attribution
· the original author must be given credit;
· for any reuse or distribution, it must be made clear to others what the license terms of this work are;
· any of these conditions can be waived if the authors gives permission.
Statutory fair use and other rights are in no way affected by the above
Author Biographies
Mohamed Berraho
Laboratoire d‟Epidémiologie, Recherche Clinique et Santé Communautaire; Fès, Maroc
Majdouline Obtel
Laboratoire d‟Epidémiologie, Recherche Clinique et Santé Communautaire; Fès, Maroc
Karima Bendahhou
Laboratoire d‟Epidémiologie, Recherche Clinique et Santé Communautaire; Fès, Maroc
Ahmed Zidouh
Association Lalla Salama de Lutte contre le cancer (ALSC), Maroc
Hassan Errihani
Institut National d‟Oncologie (INO) – Rabat, Maroc
Abdellatif Benider
Centre d‟oncologie, Centre Hospitalier Universitaire Casablanca, Maroc
Chakib Nejjari
Laboratoire d‟Epidémiologie, Recherche Clinique et Santé Communautaire; Fès, Maroc
Main Article Content
Sociodemographic factors and delay in the diagnosis of cervical cancer in Morocco
Mohamed Berraho
Majdouline Obtel
Karima Bendahhou
Ahmed Zidouh
Hassan Errihani
Abdellatif Benider
Chakib Nejjari
Abstract
Background: In Morocco, cervical cancer is the second most common cancer in women. The cases of cervical cancer are diagnosed at a late stage: 43.7% presented at stage II of diagnosis (FIGO) and 38.1% in advanced stage (stage III and IV). The main objective of this study is to investigate factors associated to late the diagnosis of cervical cancer in Morocco as measured by the stage at diagnosis and delays between first symptoms and diagnosis of cancer. Methods: Cross-sectional studies, conducted from June-2008 to June-2010 at two main oncological centers. Two-hundred cases were recruited. Stages I & II were identified as "early-stage". The dates of first-symptoms, first-consultation and first-diagnosis were used to define "Patient", "Medical" and "Total" delays. Results: Elevated risks for late stage was observed for women unmarried (OR=5.0; 95%CI: 1.43-16.66); living > 100 km from center of diagnosis (OR=4.51; 95%CI: 1.35-15.11); without a familial history of cancer (OR=14.28; 95%CI: 2.22-100) and whose was the first symptom not bleeding (OR=25; 95%CI: 1.62-300). Frequency of housewives was significantly higher for women with a "patient-delay. ≥1 month. Frequency of patients who had symptoms of .bleeding. was significantly higher for women with a "patient-delay" <1 month. Frequency of patients from urban area was significantly higher for women with a "Medical-delay" < 1 month. Elevated risks for a long "Total-delay" was observed for women aged < 50 years (OR=2.44; 95%CI: 1.24-4.76); illiterate (OR=3.85; 95%CI: 1.45-10.00) and from rural-area (OR=2.56; 95%CI: 1.25-5.26). Conclusion: Our results may represent an important tool in guiding the actions for an early diagnosis of cervical cancer.
Pan African Medical Journal 2012; 12:14
Donate
AJOL is a Non Profit Organisation that cannot function without donations.
AJOL and the millions of African and international researchers who rely on our free services are deeply grateful for your contribution.
AJOL is annually audited and was also independently assessed in 2019 by E&Y.
Your donation is guaranteed to directly contribute to Africans sharing their research output with a global readership.
Once off donations here:
For annual AJOL Supporter contributions, please view our Supporters page.
Tell us what you think and showcase the impact of your research!
Please take 5 minutes to contribute to our survey so that we can better understand the contribution that African research makes to global and African development challenges. Share your feedback to help us make sure that AJOL's services support and amplify the voices of researchers like you.